RecallDepth
Class II Terminated

Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454

This recall has been terminated (originally issued January 23, 2019).

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 19, 2018
Posted
January 23, 2019
Recall Number
D-0381-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
181,456 bottles
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed dissolution specifications

Distribution

U.S.A. nationwide

Lot / Code Info

Lot #: a) 49O005, 49O006, 49O007, 49O010, Exp 02/2019; b) 49O005, 49O009, 49O010, Exp 02/2019

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls